IXALTIS is a specialty pharmaceutical company developing proprietary therapeutics to treat genitourinary (GU) disorders with unsatisfied medical need. The company was born from the combined expertise of leading scientists specialised in this field and of experienced managers. IXALTIS has already obtained an exclusive worldwide license for three molecules from SANOFI (IXA-001, IXA-002 and IXA-003). IXALTIS has established a proprietary position covering IXA-001 for use in urogenital and other disorders based on its specific mechanism of action.
« Our company has the objective of becoming a leading developer of innovative pharmaceutical products for treating disorders of the urogenital tract, bringing to the clinic solutions for diseases that affect many people and for which there are few or no satisfactory treatments ».
Company Details
- Employees
- 2
- Founded
- -
- Address
- 3 Rue Des Satellites, Toulouse,occitanie 31400,france
- Phone
- +33 (0)4 57 26 00 76
- co****@****tis.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- ixaltis.com
- HQ
- Toulouse, Occitanie
Ixaltis Sa Questions
Ixaltis Sa's helpline number is +33 (0)4 57 26 00 76
Ixaltis Sa's website is ixaltis.com
Ixaltis Sa's LinkedIn profile is https://fr.linkedin.com/company/ixaltis-sa
Ixaltis Sa has
2 employees.
View email and phone details for 2
employees at Ixaltis Sa.
Ixaltis Sa's industry is
Biotechnology Research
Ixaltis Sa's top competitors are
Instant Zen,
Spineart,
Kerimedical Sa,
Olon France,
Total Feet,
Gaiha,
Laboratoires Aloméa,
Laboratoire Cooper,
Kuste Biopharma,
Exalia.
Ixaltis Sa's support email address is contact@ixaltis.com
Ixaltis Sa's categories are Biotechnology Research
Ixaltis Sa's founding year is 2012
